2026 Alzheimer's Association International Conference - Part 1

2026 Alzheimer's Association International Conference - Part 127 aug1 min

Luister in SpotifyWerkt ook in je browser

Apple PodcastsOpenen
YouTubeOpenen
Pocket Castsopent de podcast
Amazon Musicopent de podcast
Deezeropent de podcast

5 andere apps

Overcastopent de podcast
Player FMopent de podcast
Castroopent de podcast
Podcast Addictopent de podcast
RSSopent de podcast

In part one of this series, Drs. Greg Cooper, Trey Bateman, and Gregg Day discussed key takeaways from the 2026 Alzheimer's Association International Conference, focusing on blood-based biomarkers, anti-amyloid therapies, and other important highlights.